Hypertension Diagnostics Inc (HDII)

[Fai 2]

Thank you for your concern. We are grown and make our own choices. Read below
TORONTO, ON / ACCESSWIRE / October 2, 2019 / There appears to be a control dispute for Hypertension Diagnostics, Inc. (OTC PINK:HDII) involving Mr. Liangjian Peng and another party. HDII's attorney Stephen Mills is currently dealing with the dispute. We believe this matter will be solved very soon. Mr. Peng, CEO of HDII affirms that he is sole officer and only preferred shares holder of HDII. Mr. Peng will travel to China on October 4, 2019, he will visit ShanDong GerPang Healthcare Group to discuss further cooperation between HDII and ShanDong Gerpang Healthcare Group. Thank you for all shareholders support!